Tag: Johnson Johnson Covid Vaccine

Covid Vaccine
Johnson & Johnson Seeks Regulator Nod For Vax Trials In 12-17 Age Group In India

The American-based pharma major Johnson & Johnson (J&J) has applied to the Central Drugs Standard Control Organisation (CDSCO) for permission to conduct a vaccine trial of the Covid-19 single shot Janssen vaccine in India on children of 12-17 age group.

  • Friday, 20 August 2021
Johnson & Johnson Vax
Johnson & Johnson's Single-Dose COVID-19 Vaccine Gets Emergency Use Approval In India

The five vaccines granted Emergency Use Authorisation in India are Serum Institute's Covishield, Bharat Biotech's Covaxin, Russia's Sputnik V, Moderna and now Johnson & Johnson.

  • Saturday, 07 August 2021
Johnson & Johnson Vax
J&J's One Shot Covid Vax Effective Against Delta Variant

The vaccine is 85 percent effective against severe/critical disease and demonstrated protection against hospitalisation and death from the deadly coronavirus.

  • Friday, 02 July 2021
Johnson & Johnson Vax
FDA Extends Shelf Life Of Johnson & Johnson Covid Vaccine By 6 Weeks

Johnson & Johnson said on Thursday the US Food and Drug Administration has extended the expiration date on millions of doses of its COVID-19 vaccine by six weeks.

  • Friday, 11 June 2021
scrollToTop